Grateful for the opportunity to work on this super cool project in the @SgourakisLab π₯³
Deciding which patients can receive #CAR T therapy is an important clinical question. By uncovering the structural basis of #MHC antigen recognition by a #neuroblastoma-targeting CAR we double the patient cohort and limit off-target toxicity @SciImmunologyView quoted post on X
science.org/doi/10.1126/scβ¦